Organigram Announces Trading Date for Graduation to TSX
20 Août 2019 - 12:00PM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the
parent company of Organigram Inc. (the “Company” or “Organigram”),
a leading licensed producer of cannabis, is pleased to announce
that it has received final approval for the listing of its common
shares on the Toronto Stock Exchange (“TSX”).
Organigram’s common shares will commence trading on the TSX at
the opening on Thursday August 22, 2019, continuing to trade under
the symbol OGI.
To ensure continued and seamless trading for the Company’s
shareholders and as a result of the graduation, there will be no
further trading on the TSX Venture Exchange after Wednesday August
21, 2019. Organigram’s common shares will be delisted from the TSX
Venture Exchange at the commencement of trading on the TSX.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
Venture Exchange listed company whose wholly owned subsidiary,
Organigram Inc., is a licensed producer of cannabis and
cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and
Trailblazer. Organigram's primary facility is located in Moncton,
New Brunswick and the Company is regulated by the Cannabis Act and
the Cannabis Regulations (Canada).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that change timing for listing and delisting; including
risks as disclosed in the Company’s most recent annual information
form, management’s discussion and analysis and other Company
documents filed from time to time on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur in the disclosed
time frames. The forward-looking information included in this news
release are made as of the date of this news release and the
Company disclaims any intention or obligation, except to the extent
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise. We seek safe harbor.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190820005260/en/
For Organigram Investor Relations enquiries: Amy Schwalm
Organigram Vice President, Investor Relations
Amy.Schwalm@organigram.ca (416) 704-9057
For Organigram Media enquiries: Ray Gracewood Organigram Senior
Vice President, Marketing and Communications
rgracewood@organigram.ca (506) 645-1653
OrganiGram (TSX:OGI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
OrganiGram (TSX:OGI)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024